MCHP three-lens brief
Evidence-based stock research on MCHP. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 9.2pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 9.2pp over 30 days.
- P/E of 384 — priced for high growth; little margin of safety.
- Analyst mean target $114.00 — 29% above current (24 analysts).
- Earnings scheduled 2026-08-06.
MCHP closed at $88.33 (+0.08%) as of 2026-07-10. Market cap: $47.96B. P/E (trailing) 384.0. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $114.00 — 29% above current (24 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 9.2pp over 30 days.. Last quarter: Revenue $1.31B, net income $116.40M, free cash flow $1.14B. Watching for: 2026-08-06 earnings release (26 days out).
Why three lenses on MCHP, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MCHPacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MCHP" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MCHP brief"></iframe>